Pamidronate treatment of hypercalcemia caused by vitamin D toxicity

被引:0
作者
Chatterjee, Manjula [1 ]
Speiser, Phyllis W. [1 ,2 ]
机构
[1] Schneider Childrens Hosp, Div Pediat Endocrinol, New Hyde Pk, NY 11040 USA
[2] NYU, Sch Med, Dept Pediat, New York, NY USA
关键词
bisphosphonate; pamidronate; therapy; hypercalcemia; ergocalciferol (vitamin D) administration; dosage; toxicity;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We present a 16 month-old previously healthy boy with refractory hypercalcemia due to an overdose of an over-the-counter vitamin supplement. The patient presented to the emergency department with a few weeks' history of irritability, constipation and intermittent vomiting. His serum calcium was found to be 18 mg/dl. He was first treated with intravenous fluids, furosemide and glucocorticoids without significant improvement, but became eucalcemic within 24 hours after receiving a single dose of pamidronate. This case highlights the potential danger of high dose vitamin supplements in children, and the salutary effects of treatment with bisphosphonate.
引用
收藏
页码:1241 / 1248
页数:8
相关论文
共 50 条
[31]   Zoledronate in a patient with pamidronate refractory hypercalcemia syndrome [J].
Catharina Wenzel ;
Rupert Bartsch ;
Dagmar Hussian ;
Ursula Pluschnig ;
Gottfried J. Locker ;
Ursula Sevelda ;
Christoph C. Zielinski ;
Guenther G. Steger .
Supportive Care in Cancer, 2004, 12 :678-681
[32]   HYPERCALCEMIA AND HYPEROSTEOLYSIS IN VITAMIN-D INTOXICATION - EFFECTS OF CLODRONATE THERAPY [J].
RIZZOLI, R ;
STOERMANN, C ;
AMMANN, P ;
BONJOUR, JP .
BONE, 1994, 15 (02) :193-198
[33]   Intravenous pamidronate in combination with calcium and vitamin D: Highly effective in the treatment of low bone mineral density in inflammatory bowel disease [J].
Stokkers, PCF ;
Deley, M ;
Van Der Spek, M ;
Verberne, HJ ;
Van Deventer, SJH ;
Hommes, DW .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2006, 41 (02) :200-204
[34]   Zoledronate in a patient with pamidronate refractory hypercalcemia syndrome [J].
Wenzel, C ;
Bartsch, R ;
Hussian, D ;
Pluschnig, U ;
Locker, GJ ;
Sevelda, U ;
Zielinski, CC ;
Steger, GG .
SUPPORTIVE CARE IN CANCER, 2004, 12 (09) :678-681
[35]   Use of Pamidronate for Hypercalcemia of Malignancy in Renal Dysfunction [J].
Norman, Sarah J. ;
Reeves, David J. ;
Saum, Lindsay M. .
JOURNAL OF PHARMACY PRACTICE, 2021, 34 (04) :553-557
[36]   Use of pamidronate in the management of acute cancer-related hypercalcemia in children [J].
Young, G ;
Shende, A .
MEDICAL AND PEDIATRIC ONCOLOGY, 1998, 30 (02) :117-121
[37]   TREATMENT OF TUMOR-INDUCED HYPERCALCEMIA WITH THE BISPHOSPHONATE PAMIDRONATE - DOSE-RESPONSE RELATIONSHIP AND INFLUENCE OF TUMOR TYPE [J].
BODY, JJ ;
DUMON, JC .
ANNALS OF ONCOLOGY, 1994, 5 (04) :359-363
[38]   Hypercalcemia Associated With Tertiary Hyperparathyroidism Managed Conservatively With Pamidronate in a Hemodialysis Patient [J].
Czosnowski, Lauren M. ;
Hudson, Joanna Q. ;
Canada, Robert B. .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2009, 337 (04) :300-301
[39]   Pamidronate-induced irreversible symptomatic hypocalcemia in a dog with hypercalcemia after glucocorticoid withdrawal: a case report [J].
Oh, Ye-In ;
An, Ju-Hyun ;
Lim, Ga-Hyun ;
Park, Su-Min ;
Kim, Tae-Hee ;
Seo, Kyoung-Won ;
Youn, Hwa-Young .
BMC VETERINARY RESEARCH, 2024, 20 (01)
[40]   ANALYSIS OF SURVIVAL FOLLOWING TREATMENT OF TUMOR-INDUCED HYPERCALCEMIA WITH INTRAVENOUS PAMIDRONATE (APD) [J].
LING, PJ ;
AHERN, RP ;
HARDY, JR .
BRITISH JOURNAL OF CANCER, 1995, 72 (01) :206-209